Product Information
MYFORTIC 360 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $14.9342 per EA under NDC 00078038666. Its NADAC has been published 540 times since Nov 28, 2013.
FDA first approved this application on Feb 27, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the mycophenolic acid market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
360 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078038666
Classification
Brand
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
7/8/2026
Active Ingredients
MYCOPHENOLATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA050791FDA Approved
2/27/2004
TE Code
AB
On Market Since
2/27/2004
Pharmacological Classes
Price Statistics
The NADAC for MYFORTIC 360 MG TABLET has been published 540 times since Nov 28, 2013, and over the history we have for it it has risen 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.9342 per EA |
|---|---|
| All-time high | $14.9342 (Aug 19, 2026) |
| All-time low | $8.1771 (May 21, 2014) |
| 52-week high | $14.9342 |
| 52-week low | $14.3543 |
| Median price | $10.3407 |
| Average price | $10.6482 |
| Largest weekly change | +16.6% (Jun 19, 2024) |
| Weeks tracked | 540 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MYFORTIC 360 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MYFORTIC 360 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $14.9342 per EA (NDC 00078038666), effective Aug 19, 2026.
How has the price of MYFORTIC 360 MG TABLET changed over time?
Over the history we have for it, the NADAC for MYFORTIC 360 MG TABLET has risen 80.5%. It has been tracked across 540 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MYFORTIC 360 MG TABLET?
Since Nov 28, 2013, the NADAC for MYFORTIC 360 MG TABLET has ranged from a low of $8.1771 (May 21, 2014) to a high of $14.9342 (Aug 19, 2026), with a median of $10.3407 per EA.
Are there cheaper alternatives to MYFORTIC 360 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MYCOPHENOLIC ACID DR 360 MG TB, is $0.2265 per EA — about 98% below MYFORTIC 360 MG TABLET.
Who manufactures MYFORTIC 360 MG TABLET?
MYFORTIC 360 MG TABLET (NDC 00078038666) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.